Corbenic Partners’s CME Group CME Stock Holding History

Corbenic Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-95	Closed	-$13K	–	186
2017 Q3	$13K	Buy	+95	New	+$12K	0.02%	128

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Corbenic Partners's CME Position: Q4 2017 in Review

Corbenic Partners sold out of CME Group (CME) in Q4 2017, closing a stake of 95 shares — an estimated $13K sold.

Corbenic Partners first reported a position in CME in Q3 2017 and held it in 1 quarter. The position peaked at $13K in Q3 2017. 855 funds tracked by Wall St. Rank hold CME as of Q4 2017.

Corbenic Partners reported no remaining CME Group position as of Q4 2017 after selling out during the quarter.
Corbenic Partners sold 95 CME Group shares in Q4 2017, an estimated $13K.
Corbenic Partners first reported a position in CME Group in Q3 2017 and held it in 1 quarter.
Corbenic Partners's CME Group position peaked at $13K in Q3 2017.
855 funds tracked by Wall St. Rank held CME Group as of Q4 2017.

Based on Corbenic Partners's 13F filing for Q4 2017, filed 25 Jan 2018.